Nervenheilkunde 2019; 38(05): 280-281
DOI: 10.1055/s-0039-1685006
Vorträge
Update CMT-NET: vom molekularen Defekt zur Therapie der Charcot-Marie-Tooth Erkrankung (CMT)
Georg Thieme Verlag KG Stuttgart · New York

Entzündungsreaktionen bei CMT-Modellen: Mechanismen und Behandlungschancen

R Martini
1   Neurologische Klinik und Poliklinik des Universitätsklinikums, Kopfkliniken, Würzburg, Deutschland
› Author Affiliations
Further Information

Publication History

Publication Date:
06 May 2019 (online)

 

Previous studies from our laboratory have shown that in models for distinct forms of Charcot-Marie-Tooth neuropathy, phagocytosing macrophages mediate demyelination and perturbation of axons. One important mediator is colony-stimulating factor-1, unexpectedly expressed by endoneurial fibroblasts and essential for macrophage-mediated demyelination, Schwann cell dedifferentiation and axonopathy. Interestingly, macrophage-related inflammation is also a driving force for developing neuropathy in aging nerves. Further activities concerning the basic pathomechanisms are underway to decipher cell-cell communication within the peripheral nerves under disease conditions. As a translational approach, we developed distinct attempts to attenuate macrophage-related peripheral nerve inflammation as putative options to ameliorate disabling symptoms associated with CMT-1. These activities may pave the way for the development of treatment options for Charcot-Marie-Tooth neuropathies, but also for aging nerves.